| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Revenue | $2.7B | $2.6B | $2.5B | $2.4B | $1.9B | $1.6B | $0.4B | $1.5B |
| Cost of Revenue | $1.1B | $1.0B | $1.0B | $0.9B | $0.7B | $0.7B | $0.7B | $0.5B |
| Gross Profit | — | — | — | — | — | — | — | — |
| R&D Expense | — | — | — | — | — | — | — | — |
| SG&A Expense | — | — | — | — | — | — | — | — |
| Operating Income | $0.7B | $0.7B | $0.6B | $0.5B | $0.3B | $-0.1B | $0.1B | $0.4B |
| Net Income | $0.3B | $0.3B | $0.3B | $0.2B | $0.1B | $-0.3B | $0.2B | $0.1B |
| EPS (Basic) | $8.57 | $7.59 | $6.23 | $4.54 | $0.00 | $-5.56 | $1.26 | $3.90 |
| EPS (Diluted) | $8.47 | $7.50 | $6.16 | $4.50 | $0.00 | $-5.56 | $1.24 | $3.86 |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $14.4B | $13.3B | $13.9B | $11.5B | $10.3B | $8.2B | $8.3B | $6.8B |
| Current Assets | $9.7B | $8.5B | $8.9B | $6.8B | $5.3B | $3.5B | $3.8B | $3.4B |
| Cash & Equivalents | $0.9B | $0.6B | $1.0B | $0.9B | $0.6B | $0.9B | $0.8B | $0.5B |
| Total Liabilities | $13.2B | $11.8B | $12.1B | $9.9B | $8.2B | $6.1B | $6.2B | $5.0B |
| Current Liabilities | $9.3B | $8.3B | $8.5B | $6.3B | $4.4B | $2.7B | $3.0B | $2.3B |
| Stockholders' Equity | $1.2B | $1.5B | $1.8B | $1.6B | $1.8B | $1.9B | $1.9B | $1.8B |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $0.5B | $0.5B | $0.9B | $0.7B | $0.2B | $0.9B | $0.7B | $0.4B |
| Investing Cash Flow | $-0.7B | $-1.0B | $-2.1B | $-0.7B | $-1.6B | $-0.3B | $-1.0B | $-0.3B |
| Capital Expenditures | $0.1B | $0.1B | $0.1B | $0.1B | $0.1B | $0.1B | $0.1B | $0.1B |
| Financing Cash Flow | $0.4B | $-0.3B | $1.6B | $0.7B | $1.4B | $-0.2B | $0.7B | $-0.1B |